[HTML][HTML] N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes
J Wei, W Zhou, YF He - Journal of Gastrointestinal Oncology, 2021 - ncbi.nlm.nih.gov
Background The N6-methyladenosine (m6A) plays an important role in epigenetic
modification and tumor progression, but the modulations of m6A in hepatocellular carcinoma …
modification and tumor progression, but the modulations of m6A in hepatocellular carcinoma …
Construction of an m6A-and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape
T Zhan, W Wang, X Guan, W Bao, N Lu… - Frontiers in …, 2023 - frontiersin.org
Purpose To investigate the impact of N6-methyladenosine-(m6A) and neutrophil
extracellular traps-(NETs) related lncRNAs (MNlncRNAs) on the prognosis of hepatocellular …
extracellular traps-(NETs) related lncRNAs (MNlncRNAs) on the prognosis of hepatocellular …
Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
Y Xu, X He, J Deng, L Xiong, Y Li, X Zhang… - Frontiers in Cell and …, 2021 - frontiersin.org
Recently, N 6-methyladenosine (m6A) RNA methylation in eukaryotic mRNA has become
increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor …
increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor …
Cross-Talk Between m6A- and m5C-Related lncRNAs to Construct a Novel Signature and Predict the Immune Landscape of Colorectal Cancer Patients
W Song, J Ren, R Xiang, W Yuan, T Fu - Frontiers in immunology, 2022 - frontiersin.org
Background N6-methyladenosine (m6A) and 5-methylcytosine (m5C) can modify long non-
coding RNAs (lncRNAs), thereby affecting tumorigenesis and tumor progression. However …
coding RNAs (lncRNAs), thereby affecting tumorigenesis and tumor progression. However …
Potential prognostic value of a seven m6A-related LncRNAs signature and the correlative immune infiltration in colon adenocarcinoma
X Chai, W Qi, CY Zou, CX He, M Su, DQ Zhao - Frontiers in Genetics, 2021 - frontiersin.org
Long non-coding RNAs (lncRNAs) and their N6-methyladenosine (m6A) modifications play
an essential role in tumorigenesis and cancer progression. This study was designed to …
an essential role in tumorigenesis and cancer progression. This study was designed to …
Inflammatory Response‐Related Long Non‐Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
X Li, S Zhang, S Zhang, W Kuang… - Journal of Oncology, 2022 - Wiley Online Library
Background. Hepatocellular carcinoma (HCC) is a high mortality malignant tumor with
genetic and phenotypic heterogeneity, making predicting prognosis challenging …
genetic and phenotypic heterogeneity, making predicting prognosis challenging …
Establishment of prognostic signatures of N6-methyladenosine-related lncRNAs and their potential functions in hepatocellular carcinoma patients
X Wu, Z Deng, X Liao, X Ruan, N Qu, L Pang… - Frontiers in …, 2022 - frontiersin.org
N6-methyladenosine (m6a)-related mRNAs and lncRNAs have been explored for their
functions in several cancers. The present study aimed to identify potential signatures of m6a …
functions in several cancers. The present study aimed to identify potential signatures of m6a …
Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
Background Early recurrence is the major cause of poor prognosis in hepatocellular
carcinoma (HCC). Long non-coding RNAs (lncRNAs) are deeply involved in HCC …
carcinoma (HCC). Long non-coding RNAs (lncRNAs) are deeply involved in HCC …
Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
Y Wu, PS Wang, BG Wang, L Xu, WX Fang… - Cancer …, 2018 - Wiley Online Library
The current prognostic long noncoding RNA (lncRNA) signatures for hepatocellular
carcinoma (HCC) are still controversial and need to be optimized by systematic …
carcinoma (HCC) are still controversial and need to be optimized by systematic …
The Prognostic Value of a lncRNA Risk Model Consists of 9 m6A Regulator-Related lncRNAs in Hepatocellular Carcinoma (HCC)
Z Deng, J Hou, H Xu, Z Lei, Z Li, H Zhu… - Evolutionary …, 2023 - journals.sagepub.com
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver.
Although the RNA modification N6-methyladenine (m6A) has been reported to be involved …
Although the RNA modification N6-methyladenine (m6A) has been reported to be involved …